Greenleaf Trust Has $18.91 Million Stock Holdings in Danaher Corporation $DHR

Greenleaf Trust increased its holdings in shares of Danaher Corporation (NYSE:DHR) by 5.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 82,583 shares of the conglomerate’s stock after purchasing an additional 4,535 shares during the period. Greenleaf Trust’s holdings in Danaher were worth $18,905,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Enterprise Financial Services Corp grew its stake in Danaher by 1.4% during the fourth quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock worth $737,000 after purchasing an additional 46 shares during the period. Revolve Wealth Partners LLC grew its stake in Danaher by 2.6% during the fourth quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock worth $428,000 after purchasing an additional 47 shares during the period. Kestra Private Wealth Services LLC grew its stake in Danaher by 0.3% during the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after purchasing an additional 48 shares during the period. Norway Savings Bank grew its stake in Danaher by 0.7% during the fourth quarter. Norway Savings Bank now owns 7,063 shares of the conglomerate’s stock worth $1,617,000 after purchasing an additional 49 shares during the period. Finally, SOL Capital Management CO grew its stake in Danaher by 2.8% during the third quarter. SOL Capital Management CO now owns 1,829 shares of the conglomerate’s stock worth $363,000 after purchasing an additional 50 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the transaction, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 11.20% of the stock is owned by corporate insiders.

Danaher Stock Down 0.6%

DHR stock opened at $191.03 on Wednesday. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $242.80. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The stock’s 50 day moving average is $202.70 and its 200-day moving average is $214.59. The firm has a market capitalization of $135.19 billion, a PE ratio of 37.90, a P/E/G ratio of 2.59 and a beta of 0.95.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. During the same quarter last year, the company earned $2.14 earnings per share. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. Sell-side analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be issued a $0.40 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Friday, March 27th. Danaher’s dividend payout ratio is 31.75%.

Analyst Upgrades and Downgrades

DHR has been the subject of several recent analyst reports. KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a research note on Thursday, January 29th. Guggenheim raised their target price on Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a research note on Friday, January 2nd. Wells Fargo & Company raised their target price on Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a research note on Monday, December 15th. Evercore decreased their target price on Danaher from $254.00 to $225.00 and set an “outperform” rating for the company in a research note on Monday. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Seventeen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $253.79.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.